Health
Pharmaceutical Trials and Drug Efficacy
Eli Lilly's next-generation obesity drug showed significant weight loss in a late-stage trial, approaching the effectiveness of bariatric surgery. The company is also advancing an Alzheimer’s drug.
Coverage timeline — 1 article
STAT News
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the effectiveness seen with bariatric surgery
2026-05-21 13:28 UTC